BDX Becton Dickinson : Bullish and Bearish Analyst Opinions

Sentiment & Price 1 ideas • 1 voices • 1 sources
Sentiment Gauge
1
Bull
0
Bear
0
Watch
Bull 100% Bear 0%
Price & Sentiment
Loading chart...
Recent News Top Views
No recent news for BDX
No theses available
Feed
All Sources
YouTube
Twitter
Reddit
Substack
Insider
News
Loading...
All directions
▲ Long
▼ Short
◦ Others
Any score
LOW+
MED+
HIGH
22:45
Apr 11
Matthew McLennan Co-Head of Investment Management, Goldman Sachs We Study Billionaires
BDX is a scarce asset with margin of safety.
Becton Dickinson (BDX) is a world leader in syringes and catheters with over 50% market share, giving it scale economies, embeddedness in hospital systems, and a regenerative feedback loop for innovation. It trades at 12-13 times earnings (8% earnings yield), implying the market expects little growth, yet the company is focused, generates strong free cash flow, and uses it for dividends and buybacks. It is well-positioned to benefit from the growth of biologics and integration of technology like AI.
BDX
HIGH

About BDX Analyst Coverage

Buzzberg tracks BDX (Becton Dickinson) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.